11 stories mentioning HNGEUpdated 6d ago
Every FINWIRES story that references HNGE, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Gabriel M.I. Mecklenburg, Director, Executive Chairman & Co-Founder, on September 14, 2026, sold 150,000 shares in Hinge Health (HNGE) for $13,982,810.SEC Filing:https://www.sec.gov/Archives/edgar/data/1673743/000206278126000024/xslF345X05/form4-09152026_110906.xml
James Budge, Chief Financial Officer, on September 10, 2026, sold 55,561 shares in Hinge Health (HNGE) for $4,969,999. Following the Form 4 filing with the SEC, Budge has control over a total of 349,062 Class A common shares of the company, with 349,062 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1673743/000133817626000034/xslF345X05/form4-09112026_110907.xml
Hinge Health (HNGE) has an average rating of buy and mean price target of $101.67, according to analysts polled by FactSet.Price: $89.75, Change: $+0.42, Percent Change: +0.47%
James Pursley, President, on June 22, 2026, sold 33,000 shares in Hinge Health (HNGE) for $2,287,251. Following the Form 4 filing with the SEC, Pursley has control over a total of 740,897 Class A common shares of the company, with 740,897 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1673743/000178310826000022/xslF345X05/form4-06232026_080631.xml
Hinge Health (HNGE) has a "long runway" for growth driven by new products, expanding market opportunities and continued margin improvement, RBC Capital Markets said in a report emailed Thursday, following the company's Movement 2026 conference and investor session in Chicago.The firm highlighted Hinge Health's decision to raise its Q2 and full-year 2026 guidance, citing strong performance in April and May and management's confidence in the business through the remainder of the year. The company also introduced a "target operating model" that calls for 20% to 25% revenue growth and operating margins above 35%, which the analysts said were "achievable over the medium-term."Hinge Health could further expand its addressable market through new offerings, including HingeSelect Surgery and its Migraine program. The migraine offering has already been adopted by 300 clients covering more than 3 million "contracted lives" and represents a potential $25 billion annual market opportunity, according to the report.RBC maintained an outperform rating on Hinge Health and raised the price target to $75 from $65.Price: $64.79, Change: $+2.73, Percent Change: +4.40%
Gabriel M.I. Mecklenburg, Director, Executive Chairman & Co-Founder, on June 05, 2026, sold 50,000 shares in Hinge Health (HNGE) for $3,276,843.SEC Filing:https://www.sec.gov/Archives/edgar/data/1673743/000206278126000014/xslF345X05/form4-06062026_120628.xml
Hinge Health (HNGE) said Wednesday that a medical claims analysis of its digital musculoskeletal program found an average cost savings of $2,941 per member per year, and a threefold return on investment for employers and health plans.As a result of the program, Hinge Health members had 69% fewer surgeries, 61% fewer injections, and 68% fewer imaging scans, it said.Chronic musculoskeletal pain is a leading cause of disability and healthcare costs in the US, according to Hinge.Price: $57.69, Change: $-0.75, Percent Change: -1.28%
Gabriel M.I. Mecklenburg, Director, Executive Chairman & Co-Founder, on May 26, 2026, sold 83,333 shares in Hinge Health (HNGE) for $4,482,885.SEC Filing:https://www.sec.gov/Archives/edgar/data/1673743/000206278126000010/xslF345X05/form4-05272026_110544.xml
James Budge, Chief Financial Officer, on May 11, 2026, sold 5,906 shares in Hinge Health (HNGE) for $323,759. Following the Form 4 filing with the SEC, Budge has control over a total of 386,293 Class A common shares of the company, with 386,293 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1673743/000133817626000016/xslF345X05/form4-05122026_080552.xml
Hinge Health, Inc. Class A (HNGE) has an average rating of buy and mean price target of $68.20, according to analysts polled by FactSet.Price: $54.69, Change: $+4.94, Percent Change: +9.93%
Gabriel M.I. Mecklenburg, Director, Executive Chairman, and Co-Founder, on April 21, 2026, sold 33,333 shares in Hinge Health (HNGE) for $1,501,528.SEC Filing:https://www.sec.gov/Archives/edgar/data/1673743/000206278126000006/xslF345X05/form4-04222026_080421.xml
